Company To Ring Opening Bell At Nasdaq On November 14th
CARLSBAD, Calif., Nov. 12 /PRNewswire-FirstCall/ -- (Nasdaq: GXDX), a specialized laboratory services provider, today announced it has been ranked number nine on Deloitte's 2008 Technology Fast 500, a ranking of the 500 fastest-growing technology, media, telecommunications and life sciences companies in North America. Rankings are based on the percentage of fiscal year revenue growth over five years, from 2003-2007. Genoptix grew 28,288 percent during this period.
"We have grown tremendously by providing high-quality diagnostic services to community-based oncologists and hematologists across the country," said Dr. Tina Nova, President and CEO of Genoptix, which completed its initial public offering in November 2007. "Our growth demonstrates our ability to create value for our customers and our stockholders. Growth remains one of our top priorities in the years ahead as we continue to deliver our customized comprehensive approach to a greater number of physicians nationwide."
Dr. Nova will also ring the opening bell at the Nasdaq MarketSite at 9:30 a.m. EST on November 14th, accompanied by members of the Company's executive management team. The event is to mark the first year of operation as a public company following its IPO in November of 2007.
Founded in 1999, Genoptix has been profitable since the first quarter
of 2007 and has delivered 17 consecutive quarters of solid growth in case
volumes and in revenues. The Company's highly trained group of
hematopathologists utilizes sophisticated technology to provide integrated
testing and actionable diagnostic reports. Its diagnostic services are
designed to optimize the care of patients suffering from
|SOURCE Genoptix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved